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Overlapping cDNAs encoding human platelet glycoprotein (Gp)IX were cloned from a human erythroleukemia cell 2gtl I library. The possibly 
'full-length" cDNA of 896 base pairs (bp) includes an open reading frame (528 bp), both 5' (222 bp) and 3' (146 bp) noncoding regions, and a 
poly(A) tail. Translation predicts a signal peptide of 16 amino acids and a mature protein of 160 amino acids that includes a 24 amino acid leucine- 
rich glycoprotein (LRG) segment. Southern blot analysis uggests the presence of a single copy of the Gp IX gene, and hybridization of Gp IX 
cDNA to sorted human chromosomes localizes the Gp IX gene to chromosome 3. 
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1. INTRODUCTION 
Glycoprotein IX (Gp IX) is a small membrane 
glycoprotein found on the human platelet surface. 
Originally described by size (Mr 17 000) and pI (pH 
5.8-6.3) [1,2], Gp IX forms a 1:1 non-covalent complex 
with Gp Ib [3], a heterodimeric transmembrane protein 
consisting of a disulfide linked 140 kDa ~ chain and 22 
kDa/~ chain. Platelet adhesion to arterial blood vessels 
is mediated by the Gp Ib/Gp IX complex, which serves 
as the platelet receptor for von Willebrand factor 
(vWf), with the Gp Ib a chain providing the vWf bin- 
ding site [4,5]. The individual contribution of Gp IX to 
adherence is unknown. 
Patients with a congenital bleeding disorder, 
Bernard-Soulier syndrome, have platelets lacking all the 
components of the Gp Ib/Gp IX complex and also a 
third Gp, GpV (Mr 82 000) [1]. The molecular defect 
responsible for these deficiencies i  unknown, but a re- 
cent report indicates that in one case, a truncated Gp Ib 
a chain is correlated with the disease state [6]. 
The primary structure for the Gp Ib a and 13 chains 
has been determined [5,7,8]. We have also recently 
described a partial cDNA for Gp IX with an open 
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reading frame coding for part of the signal sequence 
and all of the mature Gp IX [9]. Gp Ib a, Gp Ib ~, and 
Gp IX all contain sequences imilar to the tandem 
repeats in leucine-rich c~2-glycoprotein (LRG) of human 
serum [10] and have one or more N-linked glycosylation 
sites. We now report the characterization of clones 
establishing the complete primary sequence of Gp IX 
and identify the chromosome containing the Gp IX 
gene. 
2. MATERIALS AND METHODS 
2.1. Materials 
[~-32pldCTP (3000 Ci/mmol) was purchased from New England 
Nuclear (Boston, MA). Nylon membranes and random priming 
reagents were obtained from Amersham (Arlington Heights, IL). 1 x 
SSC is 0.15 M NaCI, 15 mM Na3-citrate. 1 x Denhardt's solution is 
0.1%o BSA, 0.1%0 PVP, 0.1%0 Ficoll. 
2.2. Screening and sequencing 
The previously isolated Gp IX cDNA (;~H7, Fig. 1) was labelled 
with [ct-32P]dCTP to a specific activity of 1 x 108 cpm/~g by random 
priming [11], and used to screen 500 000 recombinants of a ~,gtll 
cDNA library from HEL cells [7]. Nitrocellulose filters were hybridiz- 
ed at 42°C for 16 h in 50% formamide, 5 × SSC, 1 x Denhardt's solu- 
tion, 25 mM NaHPO4, pH 7.0, 250 #g/ml yeast RNA, 10% dextran 
sulfate, and washed successively at25 °C in 2 × SSC/0.1% SDS, and 
52°C in 0.1 × SSC/0.1% SDS [12]. Hybridization positive phage 
were plaque purified, and cDNA inserts were digested, subcloned, 
and sequenced as previously described [9]. 
2.3. Northern blotting 
Isolation of total RNA from human platelets and macrophages, 
separation on denaturing agarose gels, and transfer to nitrocellulose 
have been described [13]. Probe labelling, hybridization, and wash 
conditions were as described in section 2.2. 
The nucleotide sequence reported here has been submitted to the 
EMBL/Genbank database under the accession umber X52997 
2.4. Southern blotting 
Genomic DNA was isolated from normal human lymphocytes, 
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Fig. 1. Derivation of the Gp IX cDNA sequence from three inserts. A 
restriction map is shown (top line, numbers refer to nucleotide se- 
quence) above a diagram depicting the open reading frame as boxes 
(dots = signal peptide; vertical lines = mature protein), noting the 
first base of the start (ATG) and stop (TGA) codons and the first 
codon of mature Gp IX (ACC). Three individual cloned inserts 
(kH7-previously reported [9], kL, and XE), were sequenced. 
digested overnight with restriction enzymes, separated on a 1% 
agarose gel and transferred to nylon membranes [12]. Probe labelling, 
hybridization and wash conditions were identical to those described in 
section 2.2 except that 0.1 °70 SDS was included in the hybridization 
solution. 
2.5. Chromosomal localization 
Human chromosomes were isolated and sorted directly on 
nitrocellulose discs as previously described [14,15] and hybridized to 
labelled Gp IX cDNA. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and characterization of  cDNA inserts 
Screening 5 x 105 recombinants from the HEL cell 
library yielded 16 positive clones of which 8 were plaque 
purified. All contained inserts between 500 and 850 bp 
in size. The two longest clones, designated hE and XL 
(Fig. 1) were subcloned, and their sequences were deter- 
mined on both strands, resulting in the nucleotide and 
deduced amino acid sequences hown (Fig. 2). The 5' 
non-coding region is unusually long (222 bp); however, 
the putative initiator Met codon (nt 223-235) is 30 bp 
downstream from an in-frame stop codon (nt 193-195), 
precluding the existence of a longer translation product. 
Sequence alignment of Gp IX and Gp Ib a chain shows 
striking similarity in the nucleotides immediately 
preceding their initiator Met codons (12/14 identical). 
This is potentially significant since this region contains 
the only intron in the entire gpIba gene [16,17]. 
The 16 amino acid signal peptide is typically 
hydrophobic and ends with a sequence consistent with 
a cleavage site (A-X-A) [18]. The polyadenylation 
signal AATAAA (nt 853-858) is 27 nt upstream from a 
poly(A11) tail. Hydropathy analysis of the complete se- 
quence indicates that Gp IX is a transmembrane protein 
(Fig. 3). 
CAGCTGTATCCCATAGAGTTGCCACCCAGGCCTCAGCCAGGACCTTTCA 49 
GGCCAGACAGGAGCACCTGACCAAAGGCTTCACAGCCGCCCTCACCGCCCGGCCTTCTA 108 
CGGTGTCCAGAGACAGTTAGCCAGGCCTGGGCTGGGCACACTCCACCTTCCCTAGTCAC 167 
CAGCTGGTTTCCCAGAGGAG~GGCTGAGACCCGAG~GGGAGCCAGCCTGTCCC ATG 225 
M -16 
CCT GCC TGG GGA GCC CTG TTC CTG CTC TGG GCC ACA GCA GAG GCC 270 
P A W G A L F L L W A T A E A  -I 
ACC ~G GAC TGC CCC AGC CCA TGT ACC TGC CGC GCC CTG G~ ACC 315 
T K D C P S P C T C R A L E T  15 
ATG GGG CTG TGG GTG GAC TGC AGG GGC CAC GGA CTC ACG GCC CTG 360 
M G L W V D C R G H G L T A L 30 
CCT GCC CTG CCG GCC CGC ACC CGC CAC CTT CTG CTG GCC AAC AAC 405 
P A L P A R T R H f" f, - - f ,  - - ~ - -,,[ - - ,q  - %7 - 45 
AGC CTT CAG TCC GTG CCC CCG GGA GCC TTT GAC CAC CTG CCC CAG 450 
CTG CAG ACC CTC GAT GTG ACG CAG AAC CCC TGG CAC TGT GAC TGC 495 
-~- -~- -~ ' I  L D V T Q N P W H C D C 75 . . . . . . . .  J 
AGC CTC ACC TAT CTG CGC CTC TGG CTG GAG GAC CGC ACG CCC GAG 540 
S L T Y L R L W L E D R T P E 90 
GCC CTG CTG CAG GTC CGC TGT GCC AGC CCC AGC CTC GCT GCC CAT 585 
A L L Q V R C A S P S L A A H 105 
GGC CCG CTG CGG CTG ACA GGC TAC CAG CTG GGC AGC TGT GGC TGG 630 
G P L R L T G Y Q L G S C G W 120 
CAG CTG CAG GCG TCC TGG GTG CGC CCG GGG GTC TTG TGG GAC GTG 675 
Q L Q A S W V R P G V L W D V 135 
GCG CTG GTC GCC GTG GCC GCG CTG GGC CTG GCT CTT CTG GCT GGC 720 
A L V A V A A L G L A L L A G 150 
CTG CTG TGT GCC ACC ACA GAG GCC CTG GAT TGA GCCAGGCCCCCAGAA 768 
L L C A T T E A L D stop 160 
CCTGGCTCCAGCCAGGGGGCCAGTCCCTGAGGCAGGTCCCCAGACTCCACCAAGCCTGG 827 
TCAGCCCAAACCACCAGAAGCCCAGAATAAACTGGCAGCTCAGCTGTTTTATATAAGCA 886 
AAAAA~ 896 
Fig. 2. Nucleotide and deduced amino acid sequence of human Gp 
1X. The amino terminus of the mature protein starts with + 1 ; signal 
peptide is indicated by negative numbers. Amino acids confirmed by 
Edman degradation [20] are underlined, and the putative transmem- 
brane domain is double underlined. LRG sequence is shown as a dash- 
ed box and a potential polyadenylation signal is overlined. An N- 
linked glycosylation site is marked (• ) .  
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Fig. 3. Hydropathy plot of Gp IX. The complete amino acid sequence 
of Gp IX is analyzed by the method of Kyte and Doolittle [21] with 
a 7 residue window. The two major hydrophobic peaks correspond to 
the signal peptide 0-16)  and a putative transmembrane domain 
(146-170). 
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Fig. 4. (A) Northern blot analysis of the Gp IX transcript. Total RNA 
(12 #g) from human alveolar macrophages (lanes 1 and 2) and human 
platelets (lanes 3-6) was hybridized with 32p-labelled Gp IX eDNA 
(},H7). (B) Southern blot analysis of Gp IX DNA. Human genomic 
DNA (15 #g) was digested with the indicated restriction enzymes and 
hybridized with 32p-labelled Gp IX eDNA (},E and XL). E = EcoRI ;  
K = Kpnl ;  H = HindI I I ;  P = Pstl;  S = Sacl. The high molecular 
weight band in the Hind l l l  lane is a partial digestion product (data 
not shown). Sizes of hybridizing bands were estimated by comparison 
to HindI I I  digested k phage DNA. 
3.2. Blot analys& of Gp IX 
The cDNA sequence for Gp IX appears to be nearly 
'full-length', comparing its size (896 bp) with that of the 
Gp IX transcript detected by Northern blot analysis of 
platelet mRNA (Fig. 4A). However, the transcriptional 
start site was not identified. This transcript is not found 
in human macrophages (Fig. 4A), or neutrophils [13] 
but is present in HEL cells, which have megakaryocytic 
and platelet features. This evidence supports the idea 
that Gp IX is a platelet-specific protein. 
Southern blot analysis of human genomic DNA with 
a Gp IX probe suggests that Gp IX is a small, single 
copy gene similar to Gp Ib oz, since the probe containing 
the entire Gp IX transcript hybridizes with a single ~_ 
2.0 kb SacI fragment (Fig. 4B). However, the small size 
and relative lack of intron sequences may not be 
characteristic of all LRG proteins, since the gene for 
chaoptin, another LRG protein found in Drosophila, 
contains 12 exons spanning over 6 kb [19]. 
Hybridization of labelled Gp IX cDNA to individual 
human chromosomes i  shown in Fig. 5, and multiple 
hybridizations and exposures indicate that the Gp IX 
gene is located on chromosome 3. Since the gplba gene 
is found on chromosome 17 [17], the genes are not part 
of a complex but are dispersed on separate chromo- 
somes. 
Fig. 5. Spot blot analysis of flow-sorted human chromosomes 
hybridized with 32p-labelled Gp IX eDNA (XH7). DNA from 
chromosome 3 gives the only hybridization signal above background 
level. 
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